Skip to main content

News and Media

Open Main MenuClose Main Menu

Brain Matters: OSU-CHS researchers studying semaglutide for possible addiction treatment

Dr. W. Kyle Simmons — Oklahoma State University Center for Health Sciences professor of pharmacology and physiology — is leading the Semaglutide Therapy for Alcohol Reduction study at OSU’s Hardesty Center for Clinical Research and Neuroscience to determine whether semaglutide can be used to treat alcohol use disorder.
Dr. Kelly Dunn, left, executive director of clinical treatment at the National Center for Wellness and Recovery, and Dr. W. Kyle Simmons, analyze brain scans in the Biomedical Imaging Center at the Hardesty Center for Clinical Research and Neuroscience in Tulsa.
MENUCLOSE